2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
5
Lymphoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Spondylolisthesis
1
Spinal Stenosis
1
Spinal Cord Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Intervertebral Disc Displacement
1
Intervertebral Disc Degeneration
1
Hemoglobinuria, Paroxysmal
1
Interventions
Ibandronic Acid
8
Gemcitabine
8
Doxorubicin
6
Cyclophosphamide
6
Zoledronic Acid
5
Radiation
4
Nivolumab
4
Irinotecan
4
pembrolizumab
3
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Docetaxel
3
Denosumab
3
Cisplatin
3
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
3
regorafenib
2
pegfilgrastim
2
Tranexamic Acid
2
Trabectedin
2
Surveys and Questionnaires
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiosurgery
2
Quality of Life
2
Proton Therapy
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Transplantation, Homologous
×
Clear all
NCT00841152
2021-03-16
BAGvsTCP
Turku University Hospital
Completed
120 enrolled